Tim Mattke
Analyst · Dowling & Partners
Thanks Pat. In the second quarter, we earned $167.8 million of net income or $0.46 per diluted share compared to $186.8 million or $0.49 per diluted share in the same period last year. The primary driver of the difference in net income for the second quarter of this year compared to the same period last year was the level of positive primary loss reserve development. This quarter we recognized $30 million of positive development compared to $70 million in the second quarter of 2018. For the quarter, on an annualized basis, we generated a 17.5% return on beginning shareholder's equity. Net premiums earned were essentially flat compared to the same period last year, as higher ceded premiums and lower premium yields offset the increase in premiums from a higher average insurance in force. Premium ceded were higher primarily due to the $6.8 million non-recurring termination fee to restructure our 2015 quota share reinsurance transaction. Additionally, premiums ceded modestly increased as a result of higher percentage of the insurance in force being covered by our quota share treaties and insurance-linked note transactions we executed in the capital markets including in the quarter. Net premiums earned also reflect a decrease in premium refunds due to lower claim activity, an increase of $5 million in accelerated premiums per single policy cancellations compared to the same period last year and a lower profit commission due to higher ceded losses. Beginning in the third quarter, our premiums will be modestly benefited because of 2015 quarter share transaction is now ceding 15% versus 30% in prior periods. Losses incurred consists of reserves established on new delinquency notices plus changes to previously established loss reserves. Total loss incurred were $21.8 million compared to a negative $13.4 million in the same period last year. The increase in total losses incurred reflects the level of positive loss reserve development I just mentioned. The positive development in the second quarter was the same amount we experienced in the first quarter of 2019. As we do each quarter, we review the performance of the delinquent inventory to determine what, if any changes should be made to the estimated claim rate and severity factors of previously received notices. The positive development was driven by higher-than-expected cure rates and delinquencies that are aged two years or less. We attribute this primarily to the continuation of the favorable credit cycle we're experiencing. During the quarter we received 6% more new delinquency notices that we did in the same period last year. In our view this year-over-year increase is not an indication of deteriorating credit rather it reflects that our larger more recently written books of business while having low levels of new delinquency notices received are coming into their peak loss here. Further supporting our view regarding the credit quality is that in the second quarter we received approximately 5% fewer new delinquency notices than we did in the first quarter this year and the percentage of the insured loans that we were current at the beginning of the second quarter that was subsequently reported delinquent during the quarter continues to be at a very low 1.25%. Additionally, the 2009 and forward books account for just 34% of the new delinquency notices but account for approximately 86% of the risk in force as of June 30, 2019. The claim rate on new notices received in the second quarter of 2019 was unchanged from the first quarter level of approximately 8%. This estimate reflects the current economic environment and anticipated cures and was lower than the 9.5% claim rate in the second quarter of 2018. While continuing to diminish in number, we expect that the legacy books will continue to be the primary source of new notice activity in the coming quarters. Net paid claims in the first quarter were $55 million, while the number of claims received in that quarter declined by 31% from the same period last year. This activity reflects the continued decline of the delinquency inventory. The effective average premium yield for the second quarter of 2019 was 46.5 basis points, down from 47.4 basis points in the first quarter. As I mentioned previously, this quarter we paid a non-recurring fee of $6.8 million associated with the restructuring of our 2015 quota share reinsurance transaction, which was recorded as additional premium ceded and was a primary driver of the sequential change in the effective yield. The effective yield also includes changes in the recognition of premiums on single premium policies, changes in premium refund accruals and the levels of premiums ceded to the various reinsurance transactions we have in place and associated profit commission. While there could be some volatility, we expect that the effective premium yield will trend lower in future periods. This decline is expected mainly because the older books of business written in higher premium rates continue to run off and replace the new books of business written at lower premium rates. Of course, these newer books are also expected to generate low levels of losses given the credit characteristics. Net underwriting and other expenses were $45.7 million in the second quarter of 2019 compared to $44.7 million in the same period last year. We continue to expect that for the full year 2019 expenses before reinsurance will be in line with last year. During the quarter, MGIC paid a $70 million dividend to the holding company. We expect MGIC to be able to continue to do so for the foreseeable future. The dividend [Audio Dip] strong capital position is in as well as a level of capital we anticipate being able to generate as a result of the high quality of our insurance in force. As a reminder, any dividend payments are subject to approval of our Board, and we notify the OCI to ensure it does not object to any dividend payment from MGIC. At quarter end, our consolidated cash and investments totaled $5.7 billion including $333 million of cash and investments at the holding company. Investment income increased year-over-year as a result of a larger investment portfolio and higher yield. The consolidated investment portfolio had a mix of 80% taxable and 20% tax exempt securities, pre-tax yield of 3.16% and has a duration of 4.0 years. Our debt-to-total capital ratio was approximately 17% at the end of the second quarter of 2019. At the end of the second quarter, MGIC's available assets totaled approximately $4.4 billion resulting in a $1.1 billion of excess over the required assets. During the quarter, the PMIERs excess increased due to the recent insurance linked notes transaction, however, that benefit was offset by the quota share, restructure and transfer risk from a reinsurance affiliate back to MGIC. The original reason that the business was reinsured by the affiliate was due to the fact that certain states limited the level of coverage that a primary rider could cover. After working with various state regulators, we were able to have that requirement removed. The transfer of risk was done to reduce administrative burden and really does not change the risk profile of our company. Regarding the appropriate level of excess available assets under PMIERs, it is difficult to actually manage to a specific target given the regulatory requirements for paying dividends. Some level of excess provides a nice buffer against adverse economic scenarios, as well as the potential for additional capital requirements from the GSEs, should they occur in the future. In excess of available assets under PMIERs also positions us to take advantage of new business opportunities as they occur and provide some support for our ability to pay dividends from MGIC to the holding company. Finally, I want to spend a few minutes discussing our capital position and how we are thinking about allocating capital. During the quarter, we utilized the remaining $25 million remaining under the 2018 share repurchase program and repurchased 1.8 million shares. We have an additional $200 million authorization to repurchase shares through the end of 2020. I would expect us to continue to be opportunistic in utilizing the additional authorization. When deciding when to repurchase shares, we consider a number of factors, including our internal intrinsic valuation using discounted cash flows as well as market-based metrics like price-to-book and price-to-earnings ratios, but also recognize that historically our share price has been volatile. When we evaluate strategy to allocate and utilize the capital that exists and is being created at the writing company, we first estimate how much capital is needed to support the new business that is being written. This includes both the primary business as well as the GSE risk transfer transactions that require capital support. We expect to remain active in the GSE risk transfer transactions provided the returns meet our thresholds. We also have periodic options to adjust the level of quota share reinsurance we utilize like we did with the 2015 quota share transaction and we will evaluate those options as they present themselves. And of course, we're also sending dividends now at $280 million annual run rate to the holding company. So we'll continue to analyze and discuss with the Board, the best options to deploy capital. Our first priority is to use it to support new business, but if we're not able to find appropriate returns on this capital for shareholders, then we'll examine other options that maximizes long-term shareholder value. With that, let me turn it back to Pat.